+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
DNA Sequencing Market - Global Forecast 2026-2032- Product Image
DNA Sequencing Market - Global Forecast 2026-2032- Product Image
Sale

DNA Sequencing Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083698
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The DNA Sequencing Market is projected to reach USD 25.22 Billion in 2026. It is expected to continue growing at a CAGR of 17.09%, reaching USD 65.28 Billion by 2032.

DNA sequencing has become a foundational technology for precision medicine, rare disease diagnosis, oncology, reproductive health, infectious disease surveillance, agriculture, and population-scale genomics. The industry is advancing from research-centered applications toward routine clinical, public health, and industrial use as next-generation sequencing, long-read sequencing, single-cell sequencing, and metagenomic sequencing improve analytical depth and workflow flexibility. Demand is supported by the growing clinical relevance of genomic biomarkers, broader use of companion diagnostics, and the need for faster pathogen detection and antimicrobial resistance monitoring. At the same time, DNA sequencing adoption depends on validated laboratory workflows, bioinformatics capacity, data governance, reimbursement clarity, and workforce readiness. Executive priorities are shifting from simply generating sequence data to converting genomic information into clinically interpretable, secure, and actionable insights.

Transformative Shifts in the DNA Sequencing Landscape

The DNA sequencing landscape is being reshaped by faster library preparation, higher-throughput instruments, improved read accuracy, and expanding use of long-read and multi-omics approaches. Short-read sequencing remains central for many clinical and research workflows due to established protocols and broad bioinformatics support, while long-read sequencing is gaining relevance for structural variants, repeat expansions, haplotype phasing, and complex genomic regions that are difficult to resolve with shorter reads. Clinical laboratories are increasingly emphasizing automation, sample-to-answer workflows, quality management, and interoperability with electronic health records. Public health agencies are also integrating genomic surveillance into outbreak response, building on lessons from global pathogen monitoring. The most important industry shift is the movement from episodic sequencing projects toward continuous genomic intelligence systems that link sample processing, variant interpretation, data security, and decision support.

Cumulative Impact of Artificial Intelligence on DNA Sequencing

Artificial intelligence is accelerating DNA sequencing by improving base calling, read alignment, variant prioritization, annotation, quality control, and clinical interpretation. Machine learning models are particularly valuable for detecting complex variant patterns, filtering sequencing artifacts, classifying variants of uncertain significance, and integrating genomic findings with phenotypic and clinical data. AI-enabled bioinformatics can reduce manual review burdens and support scalable analysis across oncology panels, whole-exome sequencing, whole-genome sequencing, pharmacogenomics, metagenomics, and single-cell datasets. However, the cumulative impact of AI depends on transparent model validation, bias assessment, explainability, secure data access, and compliance with medical device, laboratory, and privacy regulations. Industry leaders are increasingly adopting human-in-the-loop systems in which AI supports triage and interpretation while qualified professionals retain accountability for clinical reporting and patient safety.

Key Regional Insights for DNA Sequencing

North America remains highly advanced in clinical genomics, oncology testing, rare disease sequencing, newborn screening research, and population health initiatives, supported by mature laboratory networks, strong regulatory oversight, and deep bioinformatics capability. Europe demonstrates strong adoption through coordinated genomic strategies, privacy-focused data frameworks, cross-border research programs, and growing integration of sequencing into national healthcare pathways. Asia-Pacific is becoming a major growth engine for DNA sequencing adoption due to expanding genomic medicine programs, rising clinical research activity, broader infectious disease surveillance, and increasing investment in biotechnology infrastructure across China, Japan, India, South Korea, Australia, and ASEAN economies. Latin America is progressing through academic medical centers, public health laboratories, and regional reference networks, with Brazil and Mexico playing important roles in infectious disease genomics and hereditary disease research despite persistent gaps in funding and access. Africa’s sequencing ecosystem is strengthening through pathogen genomics, antimicrobial resistance surveillance, biodiversity research, and capacity-building programs, with sustained emphasis needed on local laboratory infrastructure, data sovereignty, and skilled bioinformatics talent. The Middle East is advancing through national genome initiatives, precision medicine investments, and hospital-based genomic services, particularly where healthcare modernization and population health programs are policy priorities.

Key Group Insights for DNA Sequencing

NATO member countries contribute to DNA sequencing through biosecurity, infectious disease monitoring, defense-related health research, and resilient genomic surveillance systems that support preparedness against biological threats. G7 countries remain central to DNA sequencing innovation, regulatory science, clinical adoption, and advanced bioinformatics, with strong roles in oncology, pharmacogenomics, rare disease diagnostics, and pathogen surveillance. The European Union is distinguished by coordinated genomics initiatives, strong ethical and privacy governance, and emphasis on interoperable genomic data use across healthcare and research, creating a structured environment for clinical sequencing expansion. BRICS economies are highly influential because they combine large populations, substantial disease diversity, growing biotechnology capabilities, and increasing public health sequencing activity, although access, standardization, and workforce development vary widely. ASEAN countries are strengthening DNA sequencing capabilities through infectious disease surveillance, oncology research, agricultural genomics, and academic-clinical partnerships, while uneven laboratory infrastructure and reimbursement policies continue to shape adoption patterns across member states. The GCC is prioritizing genomic medicine through national health transformation agendas, population genomics, rare disease diagnosis, and precision oncology, supported by modern hospital systems and rising interest in data-driven healthcare.

Key Country Insights for DNA Sequencing

The United States leads in clinical DNA sequencing implementation across oncology, rare disease, reproductive health, pharmacogenomics, and public health genomics, supported by advanced laboratories, regulatory oversight, and extensive biomedical research networks. China has substantial sequencing capacity across population genomics, reproductive health, oncology, agriculture, and infectious disease surveillance, with growing emphasis on domestic innovation and data governance. Germany is advancing genomic diagnostics through strong clinical laboratories, translational research, and industrial biotechnology capabilities, while the United Kingdom has built one of the most structured national genomics environments, integrating sequencing into healthcare pathways, cancer diagnostics, rare disease programs, and population genomics. Canada emphasizes precision health, rare disease research, cancer genomics, and public health sequencing, with attention to equitable access across provinces and remote communities. Japan combines advanced clinical research, cancer genomics, aging-related studies, and high-quality laboratory standards, while India is rapidly strengthening its genomics ecosystem through population-scale research, rare disease initiatives, pathogen sequencing, agriculture, and cost-sensitive diagnostics. France is focusing on national genomic medicine implementation, oncology, rare disease diagnostics, and data governance. Mexico is expanding sequencing through infectious disease monitoring, hereditary cancer research, and academic medical collaborations, while Brazil has a prominent role in Latin American genomics through pathogen surveillance, biodiversity-related sequencing, and clinical research. South Korea is advancing precision medicine, oncology sequencing, rare disease diagnosis, and digital health integration through sophisticated hospital systems and national biotechnology priorities. Italy and Spain are expanding clinical sequencing in oncology, inherited disease, reproductive medicine, and academic hospital networks. Australia supports sequencing through national genomic medicine programs, public health genomics, Indigenous health considerations, and strong research infrastructure. Russia maintains sequencing activity across biomedical research, infectious disease monitoring, and agriculture, though integration into routine clinical care is shaped by infrastructure and policy conditions.

Actionable Recommendations for DNA Sequencing Leaders

Industry leaders should prioritize clinically validated sequencing workflows, scalable bioinformatics, and secure data architectures that support interoperability with laboratory information systems and electronic health records. Organizations expanding into clinical DNA sequencing should invest in accreditation-ready quality management, standardized variant classification, proficiency testing, and multidisciplinary genomic interpretation teams. To improve adoption, leaders should align sequencing services with clear use cases such as oncology therapy selection, rare disease diagnosis, infectious disease surveillance, pharmacogenomics, and reproductive health. AI should be deployed selectively for high-value functions such as quality control, variant prioritization, and report generation, with documented validation and human oversight. Partnerships with hospitals, public health agencies, academic centers, and payer stakeholders can improve evidence generation, clinical utility assessment, and reimbursement readiness. Executives should also strengthen cybersecurity, consent management, data localization compliance, and long-term genomic data stewardship to maintain trust in sequencing-enabled healthcare.

Research Methodology

This executive summary is developed using a structured secondary research approach based on verified public sources, including peer-reviewed scientific literature, clinical practice guidelines, regulatory agency publications, public health genomics resources, national genomics program documentation, standards-setting bodies, and healthcare policy references. The analysis emphasizes evidence-backed trends in sequencing technologies, clinical implementation, bioinformatics, artificial intelligence, regional adoption, and governance requirements. Information was assessed for relevance, recency, source credibility, and consistency across independent references. The methodology avoids speculative market sizing, market share analysis, and forecasting, focusing instead on observable industry developments, validated applications, policy direction, and operational implications for stakeholders in DNA sequencing.

Conclusion

DNA sequencing is moving from a specialized research capability to a core infrastructure for precision medicine, public health, and biological innovation. The most significant opportunities lie in clinically actionable genomics, AI-assisted interpretation, long-read sequencing, pathogen surveillance, population health programs, and secure integration of genomic data into healthcare systems. Adoption will be strongest where laboratories can demonstrate analytical validity, clinical utility, regulatory compliance, data protection, and sustainable reimbursement pathways. Regional and country-level progress shows that DNA sequencing is no longer concentrated in a single geography; it is becoming a global capability shaped by healthcare priorities, public health preparedness, and biotechnology investment. Organizations that combine robust sequencing workflows with trusted interpretation, ethical data governance, and clear clinical value will be best positioned to lead the next phase of genomic transformation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. DNA Sequencing Market, by Offerings
7.1. Introduction
7.2. Consumables & Reagents
7.2.1. Enzymes & Buffers
7.2.2. Primers & Probes
7.2.3. Sequencing Kits
7.3. Instruments & Platforms
7.3.1. DNA Sequencers
7.3.2. Library Preparation Systems
7.3.3. PCR Machines
7.4. Services
7.4.1. Contract Sequencing
7.4.2. Bioinformatics & Data Analysis Services
7.5. Software
7.5.1. Base Calling Software
7.5.2. Clinical Interpretation Platforms
7.5.3. Structural Variant Detection
8. DNA Sequencing Market, by Technology Type
8.1. Introduction
8.2. Next-Generation Sequencing (NGS)
8.2.1. Sequencing by Synthesis
8.2.2. Nanopore Sequencing
8.2.3. Ion Semiconductor Sequencing
8.3. Sanger Sequencing
8.4. Third-Generation Sequencing (TGS)
8.5. Epigenetic Sequencing
8.5.1. Bisulfite Sequencing
8.5.2. ChIP sequencing
9. DNA Sequencing Market, by Sample Type
9.1. Introduction
9.2. Human Samples
9.2.1. Blood
9.2.2. Saliva & Buccal Swab
9.2.3. Urine
9.2.4. Cell-Free DNA
9.2.5. Tissue
9.2.6. Plasma
9.3. Animal Samples
9.4. Plant Samples
9.4.1. Leaf
9.4.2. Root
9.4.3. Seed
9.5. Microbial Samples
9.5.1. Bacteria
9.5.2. Viruses
9.5.3. Fungi
9.5.4. Archaea
10. DNA Sequencing Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.2.1. Oncology
10.2.2. Infectious Disease Diagnosis
10.2.3. Rare Disease & Genetic Disorder Testing
10.2.4. Reproductive Health & Prenatal Testing
10.2.5. Newborn Screening
10.3. Research Applications
10.3.1. Genomics & Transcriptomics
10.3.2. Functional Genomics
10.3.3. Epigenetics Research
10.4. Drug Discovery & Development
10.4.1. Biomarker Discovery
10.4.2. Companion Diagnostics
10.4.3. Target Identification & Validation
10.5. Agrigenomics
10.5.1. Plant Breeding & Trait Discovery
10.5.2. Crop Pathogen Surveillance
10.6. Forensics & Security
10.6.1. Human Identification
10.6.2. Criminal Investigation
10.6.3. Disaster Victim Identification
11. DNA Sequencing Market, by End User
11.1. Introduction
11.2. Academic & Research Institutions
11.2.1. Government Research Institutes
11.2.2. University Labs
11.3. Contract Research Organizations
11.4. Hospitals & Diagnostic Laboratories
11.5. Pharmaceutical & Biotechnology Companies
12. DNA Sequencing Market, by Region
12.1. North America
12.2. Europe
12.3. Asia-Pacific
12.4. Latin America
12.5. Africa
12.6. Middle East
13. DNA Sequencing Market, by Group
13.1. NATO
13.2. G7
13.3. European Union
13.4. BRICS
13.5. ASEAN
13.6. GCC
14. DNA Sequencing Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. United Kingdom
14.5. Canada
14.6. Japan
14.7. India
14.8. France
14.9. Mexico
14.10. Brazil
14.11. South Korea
14.12. Italy
14.13. Australia
14.14. Russia
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Illumina, Inc.
16.2. Thermo Fisher Scientific Inc.
16.3. BGI Genomics Co., Ltd.
16.4. Oxford Nanopore Technologies PLC
16.5. Pacific Biosciences of California, Inc.
16.6. F. Hoffmann-La Roche Ltd.
16.7. Novogene Co, Ltd.
16.8. Laboratory Corporation of America Holdings
16.9. Eurofins Scientific SE
16.10. QIAGEN N.V.
16.11. Azenta, Inc.
16.12. Agilent Technologies, Inc.
16.13. Twist Bioscience Corporation
16.14. 10x Genomics, Inc.
16.15. Abbott Laboratories
16.16. AbbVie Inc.
16.17. Becton, Dickinson and Company
16.18. Bio-Rad Laboratories, Inc.
16.19. BioChain Institute Inc.
16.20. Charles River Laboratories International, Inc.
16.21. Danaher Corporation
16.22. Eppendorf SE
16.23. GeneDx, LLC
16.24. Genomics England
16.25. Genscript Biotech Corporation
16.26. Johnson & Johnson Services, Inc.
16.27. Macrogen Inc.
16.28. Merck KGaA
16.29. Myriad Genetics, Inc.
16.30. Novartis AG
16.31. Partek Inc.
16.32. PerkinElmer, Inc.
16.33. Sartorius AG
16.34. Shimadzu Corporation
List of Figures
FIGURE 1. GLOBAL DNA SEQUENCING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DNA SEQUENCING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DNA SEQUENCING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DNA SEQUENCING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DNA SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DNA SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DNA SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL DNA SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DNA SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DNA SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DNA SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DNA SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DNA SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DNA SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL DNA SEQUENCING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL DNA SEQUENCING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DNA SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ENZYMES & BUFFERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ENZYMES & BUFFERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ENZYMES & BUFFERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PRIMERS & PROBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PRIMERS & PROBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PRIMERS & PROBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SEQUENCING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SEQUENCING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SEQUENCING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INSTRUMENTS & PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INSTRUMENTS & PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL INSTRUMENTS & PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DNA SEQUENCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DNA SEQUENCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DNA SEQUENCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL LIBRARY PREPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL LIBRARY PREPARATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL LIBRARY PREPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PCR MACHINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PCR MACHINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PCR MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CONTRACT SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CONTRACT SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CONTRACT SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BASE CALLING SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BASE CALLING SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BASE CALLING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CLINICAL INTERPRETATION PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CLINICAL INTERPRETATION PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CLINICAL INTERPRETATION PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL STRUCTURAL VARIANT DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL STRUCTURAL VARIANT DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL STRUCTURAL VARIANT DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SEQUENCING BY SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SEQUENCING BY SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SEQUENCING BY SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NANOPORE SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NANOPORE SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NANOPORE SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ION SEMICONDUCTOR SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ION SEMICONDUCTOR SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ION SEMICONDUCTOR SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SANGER SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SANGER SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SANGER SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL THIRD-GENERATION SEQUENCING (TGS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL THIRD-GENERATION SEQUENCING (TGS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL THIRD-GENERATION SEQUENCING (TGS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL EPIGENETIC SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL EPIGENETIC SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL EPIGENETIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BISULFITE SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BISULFITE SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BISULFITE SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CHIP SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CHIP SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CHIP SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DNA SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HUMAN SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HUMAN SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HUMAN SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SALIVA & BUCCAL SWAB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL SALIVA & BUCCAL SWAB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL SALIVA & BUCCAL SWAB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CELL-FREE DNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CELL-FREE DNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CELL-FREE DNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PLASMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PLASMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PLASMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ANIMAL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ANIMAL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ANIMAL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PLANT SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PLANT SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PLANT SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL LEAF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL LEAF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL LEAF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ROOT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ROOT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ROOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL SEED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL SEED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL SEED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BACTERIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BACTERIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BACTERIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL VIRUSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL VIRUSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL VIRUSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL FUNGI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL FUNGI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL FUNGI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ARCHAEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ARCHAEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ARCHAEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL INFECTIOUS DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL RARE DISEASE & GENETIC DISORDER TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL RARE DISEASE & GENETIC DISORDER TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL RARE DISEASE & GENETIC DISORDER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL REPRODUCTIVE HEALTH & PRENATAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL REPRODUCTIVE HEALTH & PRENATAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL REPRODUCTIVE HEALTH & PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL NEWBORN SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL NEWBORN SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL RESEARCH APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL RESEARCH APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL FUNCTIONAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL EPIGENETICS RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL EPIGENETICS RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL EPIGENETICS RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL TARGET IDENTIFICATION & VALIDATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL TARGET IDENTIFICATION & VALIDATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL TARGET IDENTIFICATION & VALIDATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL AGRIGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL AGRIGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL AGRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL PLANT BREEDING & TRAIT DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL PLANT BREEDING & TRAIT DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL PLANT BREEDING & TRAIT DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL CROP PATHOGEN SURVEILLANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL CROP PATHOGEN SURVEILLANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL CROP PATHOGEN SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL FORENSICS & SECURITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL FORENSICS & SECURITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL FORENSICS & SECURITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL HUMAN IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL HUMAN IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL HUMAN IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL CRIMINAL INVESTIGATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL CRIMINAL INVESTIGATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL CRIMINAL INVESTIGATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL DISASTER VICTIM IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL DISASTER VICTIM IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL DISASTER VICTIM IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL DNA SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL GOVERNMENT RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL GOVERNMENT RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL GOVERNMENT RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL UNIVERSITY LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL UNIVERSITY LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL UNIVERSITY LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
TABLE 215. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY INSTRUMENTS & PLATFORMS, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY EPIGENETIC SEQUENCING, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY HUMAN SAMPLES, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY PLANT SAMPLES, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY AGRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY FORENSICS & SECURITY, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA DNA SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 234. EUROPE DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 235. EUROPE DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
TABLE 236. EUROPE DNA SEQUENCING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 237. EUROPE DNA SEQUENCING MARKET SIZE, BY INSTRUMENTS & PLATFORMS, 2018-2032 (USD MILLION)
TABLE 238. EUROPE DNA SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 239. EUROPE DNA SEQUENCING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 240. EUROPE DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 241. EUROPE DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2018-2032 (USD MILLION)
TABLE 242. EUROPE DNA SEQUENCING MARKET SIZE, BY EPIGENETIC SEQUENCING, 2018-2032 (USD MILLION)
TABLE 243. EUROPE DNA SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 244. EUROPE DNA SEQUENCING MARKET SIZE, BY HUMAN SAMPLES, 2018-2032 (USD MILLION)
TABLE 245. EUROPE DNA SEQUENCING MARKET SIZE, BY PLANT SAMPLES, 2018-2032 (USD MILLION)
TABLE 246. EUROPE DNA SEQUENCING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
TABLE 247. EUROPE DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 248. EUROPE DNA SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 249. EUROPE DNA SEQUENCING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 250. EUROPE DNA SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 251. EUROPE DNA SEQUENCING MARKET SIZE, BY AGRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 252. EUROPE DNA SEQUENCING MARKET SIZE, BY FORENSICS & SECURITY, 2018-2032 (USD MILLION)
TABLE 253. EUROPE DNA SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. EUROPE DNA SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY INSTRUMENTS & PLATFORMS, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY EPIGENETIC SEQUENCING, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY HUMAN SAMPLES, 2018-2032 (USD MILLION)
TABLE 266. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY PLANT SAMPLES, 2018-2032 (USD MILLION)
TABLE 267. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
TABLE 268. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 269. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 270. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 271. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 272. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY AGRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 273. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY FORENSICS & SECURITY, 2018-2032 (USD MILLION)
TABLE 274. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 275. ASIA-PACIFIC DNA SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 276. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 277. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
TABLE 278. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 279. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY INSTRUMENTS & PLATFORMS, 2018-2032 (USD MILLION)
TABLE 280. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 281. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 282. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 283. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2018-2032 (USD MILLION)
TABLE 284. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY EPIGENETIC SEQUENCING, 2018-2032 (USD MILLION)
TABLE 285. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 286. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY HUMAN SAMPLES, 2018-2032 (USD MILLION)
TABLE 287. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY PLANT SAMPLES, 2018-2032 (USD MILLION)
TABLE 288. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
TABLE 289. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 290. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 291. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 292. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 293. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY AGRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 294. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY FORENSICS & SECURITY, 2018-2032 (USD MILLION)
TABLE 295. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 296. LATIN AMERICA DNA SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 297. AFRICA DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 298. AFRICA DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
TABLE 299. AFRICA DNA SEQUENCING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 300. AFRICA DNA SEQUENCING MARKET SIZE, BY INSTRUMENTS & PLATFORMS, 2018-2032 (USD MILLION)
TABLE 301. AFRICA DNA SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 302. AFRICA DNA SEQUENCING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 303. AFRICA DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 304. AFRICA DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2018-2032 (USD MILLION)
TABLE 305. AFRICA DNA SEQUENCING MARKET SIZE, BY EPIGENETIC SEQUENCING, 2018-2032 (USD MILLION)
TABLE 306. AFRICA DNA SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 307. AFRICA DNA SEQUENCING MARKET SIZE, BY HUMAN SAMPLES, 2018-2032 (USD MILLION)
TABLE 308. AFRICA DNA SEQUENCING MARKET SIZE, BY PLANT SAMPLES, 2018-2032 (USD MILLION)
TABLE 309. AFRICA DNA SEQUENCING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
TABLE 310. AFRICA DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 311. AFRICA DNA SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 312. AFRICA DNA SEQUENCING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 313. AFRICA DNA SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 314. AFRICA DNA SEQUENCING MARKET SIZE, BY AGRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 315. AFRICA DNA SEQUENCING MARKET SIZE, BY FORENSICS & SECURITY, 2018-2032 (USD MILLION)
TABLE 316. AFRICA DNA SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 317. AFRICA DNA SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 318. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 319. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
TABLE 320. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 321. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY INSTRUMENTS & PLATFORMS, 2018-2032 (USD MILLION)
TABLE 322. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 323. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 324. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 325. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2018-2032 (USD MILLION)
TABLE 326. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY EPIGENETIC SEQUENCING, 2018-2032 (USD MILLION)
TABLE 327. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 328. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY HUMAN SAMPLES, 2018-2032 (USD MILLION)
TABLE 329. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY PLANT SAMPLES, 2018-2032 (USD MILLION)
TABLE 330. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
TABLE 331. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 332. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 333. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 334. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 335. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY AGRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 336. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY FORENSICS & SECURITY, 2018-2032 (USD MILLION)
TABLE 337. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 338. MIDDLE EAST DNA SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 339. GLOBAL DNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 340. NATO DNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 341. NATO DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
TABLE 342. NATO DNA SEQUENCING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 343. NATO DNA SEQUENCING MARKET SIZE, BY INSTRUMENTS & PLATFORMS, 2018-2032 (USD MILLION)
TABLE 344. NATO DNA SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 345. NATO DNA SEQUENCING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 346. NATO DNA SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 347. NATO DNA SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2018-2032 (USD MILLION)
TABLE 348. NATO DNA SEQUENCING MARKET SIZE, BY EPIGENETIC SEQUENCING, 2018-2032 (USD MILLION)
TABLE 349. NATO DNA SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 350. NATO DNA SEQUENCING MARKET SIZE, BY HUMAN SAMPLES, 2018-2032 (USD MILLION)
TABLE 351. NATO DNA SEQUENCING MARKET SIZE, BY PLANT SAMPLES, 2018-2032 (USD MILLION)
TABLE 352. NATO DNA SEQUENCING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
TABLE 353. NATO DNA SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 354. NATO DNA SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 355. NATO DNA SEQUENCING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 356. NATO DNA SEQUENCING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 357. NATO DNA SEQUENCING MARKET SIZE, BY AGRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 358. NATO DNA SEQUENCING MARKET SIZE, BY FORENSICS & SECURITY, 2018-2032 (USD MILLION)
TABLE 359. NATO DNA SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 360. NATO DNA SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 361. G7 DNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 362. G7 DNA SEQUENCING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
TABLE 363. G7 DNA SEQUENCING MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
TABLE 364. G7 DNA SEQUENCING MARKET SIZE, BY INSTRUMENTS & PLATFORMS, 2018-2032 (USD MILLION)
TABLE 365. G7 DNA SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 366. G7 DNA SEQUENCING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD

Companies Mentioned

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • BGI Genomics Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novogene Co, Ltd.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific SE
  • QIAGEN N.V.
  • Azenta, Inc.
  • Agilent Technologies, Inc.
  • Twist Bioscience Corporation
  • 10x Genomics, Inc.
  • Abbott Laboratories
  • AbbVie Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioChain Institute Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Eppendorf SE
  • GeneDx, LLC
  • Genomics England
  • Genscript Biotech Corporation
  • Johnson & Johnson Services, Inc.
  • Macrogen Inc.
  • Merck KGaA
  • Myriad Genetics, Inc.
  • Novartis AG
  • Partek Inc.
  • PerkinElmer, Inc.
  • Sartorius AG
  • Shimadzu Corporation

Table Information

Report AttributeDetails
No. of Pages181
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 25.22 Billion
Forecasted Market Value ( USD ) by 2032 $ 65.28 Billion
Compound Annual Growth Rate17.0%
Regions CoveredGlobal
No. of Companies Mentioned34

Related Topics

Related Reports

DNA Sequencing Machine Market - Global Forecast 2025-2030 - Product Image

DNA Sequencing Machine Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
DNA Sequencing - Global Strategic Business Report - Product Image

DNA Sequencing - Global Strategic Business Report

  • Report
  • 392 Pages
  • Global
From
DNA Sequencing Market Size, Share & Trends Analysis Report by Product & Service, Technology, Workflow, Application, End-use, and Segment Forecasts, 2026-2033 - Product Image

DNA Sequencing Market Size, Share & Trends Analysis Report by Product & Service, Technology, Workflow, Application, End-use, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
DNA Sequencing Products Market Report by Product Type, Application, End-User, and Region 2026-2034 - Product Image

DNA Sequencing Products Market Report by Product Type, Application, End-User, and Region 2026-2034

  • Report
  • 142 Pages
  • Global
From
Deoxyribonucleic Acid (DNA) Sequencing in Drug Discovery Market Report 2026 - Product Image

Deoxyribonucleic Acid (DNA) Sequencing in Drug Discovery Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.